151 related articles for article (PubMed ID: 9231820)
1. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure.
Mohri M; Egashira K; Tagawa T; Kuga T; Tagawa H; Harasawa Y; Shimokawa H; Takeshita A
Hypertension; 1997 Jul; 30(1 Pt 1):50-6. PubMed ID: 9231820
[TBL] [Abstract][Full Text] [Related]
2. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
[TBL] [Abstract][Full Text] [Related]
3. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
[TBL] [Abstract][Full Text] [Related]
4. Importance of nitric oxide in the coronary artery at rest and during pacing in humans.
Nishikawa Y; Ogawa S
J Am Coll Cardiol; 1997 Jan; 29(1):85-92. PubMed ID: 8996299
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients.
Shiode N; Nakayama K; Morishima N; Yamagata T; Matsuura H; Kajiyama G
Am Heart J; 1996 Jun; 131(6):1051-7. PubMed ID: 8644581
[TBL] [Abstract][Full Text] [Related]
7. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction.
Drexler H; Hablawetz E; Lu W; Riede U; Christes A
Circulation; 1992 Jul; 86(1):255-62. PubMed ID: 1617777
[TBL] [Abstract][Full Text] [Related]
9. Magnesium causes nitric oxide independent coronary artery vasodilation in humans.
Teragawa H; Kato M; Yamagata T; Matsuura H; Kajiyama G
Heart; 2001 Aug; 86(2):212-6. PubMed ID: 11454846
[TBL] [Abstract][Full Text] [Related]
10. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina.
Egashira K; Katsuda Y; Mohri M; Kuga T; Tagawa T; Shimokawa H; Takeshita A
J Am Coll Cardiol; 1996 May; 27(6):1444-9. PubMed ID: 8626956
[TBL] [Abstract][Full Text] [Related]
11. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
Tousoulis D; Tentolouris C; Crake T; Toutouzas P; Davies G
J Am Coll Cardiol; 1997 May; 29(6):1256-62. PubMed ID: 9137221
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide activity in the atherosclerotic human coronary circulation.
Quyyumi AA; Dakak N; Mulcahy D; Andrews NP; Husain S; Panza JA; Cannon RO
J Am Coll Cardiol; 1997 Feb; 29(2):308-17. PubMed ID: 9014982
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in coronary vasomotion during handgrip exercise.
Nishikawa Y; Kanki H; Ogawa S
Am Heart J; 1997 Nov; 134(5 Pt 1):967-73. PubMed ID: 9398111
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis.
Kato M; Shiode N; Yamagata T; Matsuura H; Kajiyama G
Heart; 1997 Nov; 78(5):493-8. PubMed ID: 9415011
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin causes coronary vasodilation in humans: effects of inhibition of nitric oxide synthesis.
Ueda K; Teragawa H; Kimura M; Matsuda K; Higashi Y; Yamagata T; Oshima T; Yoshizumi M; Chayama K
J Cardiovasc Pharmacol; 2005 Oct; 46(4):534-9. PubMed ID: 16160609
[TBL] [Abstract][Full Text] [Related]
16. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation.
Duffy SJ; Castle SF; Harper RW; Meredith IT
Circulation; 1999 Nov; 100(19):1951-7. PubMed ID: 10556220
[TBL] [Abstract][Full Text] [Related]
17. Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks.
Goodhart DM; Anderson TJ
Am J Cardiol; 1998 Nov; 82(9):1034-9. PubMed ID: 9817477
[TBL] [Abstract][Full Text] [Related]
18. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans.
Egashira K; Katsuda Y; Mohri M; Kuga T; Tagawa T; Kubota T; Hirakawa Y; Takeshita A
Circ Res; 1996 Aug; 79(2):331-5. PubMed ID: 8756012
[TBL] [Abstract][Full Text] [Related]
19. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.
Fukuda Y; Teragawa H; Matsuda K; Yamagata T; Matsuura H; Chayama K
Heart; 2002 Mar; 87(3):264-9. PubMed ID: 11847169
[TBL] [Abstract][Full Text] [Related]
20. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.
Kugiyama K; Yasue H; Ohgushi M; Motoyama T; Kawano H; Inobe Y; Hirashima O; Sugiyama S
J Am Coll Cardiol; 1996 Nov; 28(5):1161-7. PubMed ID: 8890810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
